95 related articles for article (PubMed ID: 33085762)
21. Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production.
Fan J; Zhang X; Wang S; Chen W; Li Y; Zeng X; Wang Y; Luan J; Li L; Wang Z; Sun X; Shen B; Ju D
Cell Death Dis; 2019 Aug; 10(9):626. PubMed ID: 31427566
[TBL] [Abstract][Full Text] [Related]
22. Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells.
Li Y; Chen Y; Miao L; Wang Y; Yu M; Yan X; Zhao Q; Cai H; Xiao Y; Huang G
Cancer Lett; 2021 Jan; 497():212-220. PubMed ID: 33132120
[TBL] [Abstract][Full Text] [Related]
23. A milbemycin compound isolated from Streptomyces Sp. FJS31-2 with cytotoxicity and reversal of cisplatin resistance activity in A549/DDP cells.
Li XQ; Yue CW; Xu WH; Lü YH; Huang YJ; Tian P; Liu T
Biomed Pharmacother; 2020 Aug; 128():110322. PubMed ID: 32505822
[TBL] [Abstract][Full Text] [Related]
24. Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis.
Jan YH; Lai TC; Yang CJ; Lin YF; Huang MS; Hsiao M
J Hematol Oncol; 2019 Jan; 12(1):12. PubMed ID: 30696468
[TBL] [Abstract][Full Text] [Related]
25. Size-dependent cellular uptake and TLR4 attenuation by gold nanoparticles in lung adenocarcinoma cells.
Vyas SP; Goswami R
Nanomedicine (Lond); 2019 Feb; 14(3):229-253. PubMed ID: 30657415
[TBL] [Abstract][Full Text] [Related]
26. Decoding Transcriptome Dynamics of Genome-Encoded Polyadenylation and Autoregulation with Small-Molecule Modulators of Alternative Polyadenylation.
Araki S; Nakayama Y; Sano O; Nakao S; Shimizu-Ogasawara M; Toyoshiba H; Nakanishi A; Aparicio S
Cell Chem Biol; 2018 Dec; 25(12):1470-1484.e5. PubMed ID: 30293940
[TBL] [Abstract][Full Text] [Related]
27. JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progression.
Mohrherr J; Haber M; Breitenecker K; Aigner P; Moritsch S; Voronin V; Eferl R; Moriggl R; Stoiber D; Győrffy B; Brcic L; László V; Döme B; Moldvay J; Dezső K; Bilban M; Popper H; Moll HP; Casanova E
Int J Cancer; 2019 Dec; 145(12):3376-3388. PubMed ID: 31407334
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide, Population-Based Cohort Study.
Li CL; Hsia TC; Li CH; Chen KJ; Yang YH; Yang ST
Integr Cancer Ther; 2019; 18():1534735419827079. PubMed ID: 30836771
[TBL] [Abstract][Full Text] [Related]
29. Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells.
Sadava D; Ahn J; Zhan M; Pang ML; Ding J; Kane SE
Cancer Chemother Pharmacol; 2002 Apr; 49(4):261-6. PubMed ID: 11914903
[TBL] [Abstract][Full Text] [Related]
30. One-Step Microfluidic Coating of Phospholipid Microbubbles with Natural Alginate Polymer as a Delivery System for Human Epithelial Lung Adenocarcinoma.
Ilhan-Ayisigi E; Saglam-Metiner P; Manzi G; Giannasi K; van Hoeve W; Yesil-Celiktas O
Macromol Biosci; 2020 Jun; 20(6):e2000084. PubMed ID: 32346989
[TBL] [Abstract][Full Text] [Related]
31. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
32. Glycine metabolomic changes induced by anticancer agents in A549 cells.
Guo K; Cao Y; Li Z; Zhou X; Ding R; Chen K; Liu Y; Qiu Y; Wu Z; Fang M
Amino Acids; 2020 May; 52(5):793-809. PubMed ID: 32430875
[TBL] [Abstract][Full Text] [Related]
33. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Biological and In Silico Evaluation of Pure Nucleobase-Containing Spiro (Indane-Isoxazolidine) Derivatives as Potential Inhibitors of MDM2-p53 Interaction.
Maiuolo L; Algieri V; Russo B; Tallarida MA; Nardi M; Di Gioia ML; Merchant Z; Merino P; Delso I; De Nino A
Molecules; 2019 Aug; 24(16):. PubMed ID: 31405162
[TBL] [Abstract][Full Text] [Related]
35. Identification SYT13 as a novel biomarker in lung adenocarcinoma.
Zhang L; Fan B; Zheng Y; Lou Y; Cui Y; Wang K; Zhang T; Tan X
J Cell Biochem; 2020 Feb; 121(2):963-973. PubMed ID: 31625195
[TBL] [Abstract][Full Text] [Related]
36. Esterase-sensitive cleavable histone deacetylase inhibitor-coupled hyaluronic acid nanoparticles for boosting anticancer activities against lung adenocarcinoma.
Lee SY; Hong EH; Jeong JY; Cho J; Seo JH; Ko HJ; Cho HJ
Biomater Sci; 2019 Nov; 7(11):4624-4635. PubMed ID: 31451819
[TBL] [Abstract][Full Text] [Related]
37. [High expression of VEGFR3 is positively associated with poor prognosis in lung adenocarcinoma].
Li J; Zhang W; Xia H; Liu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1023-1029. PubMed ID: 31878999
[TBL] [Abstract][Full Text] [Related]
38. Bushenshugan Formula Attenuates the Development of Lung Cancer by Inhibiting Epithelial-Mesenchymal Transition.
Fan Z; Xue W; Dou M; Li L; Lu J; Ma B; Deng X; Zhang M; Zhai Y; Wang S; Zhao J
Cell Physiol Biochem; 2018; 47(5):1977-1988. PubMed ID: 29969756
[TBL] [Abstract][Full Text] [Related]
39. Caffeic acid phenethyl ester down-regulates claudin-2 expression at the transcriptional and post-translational levels and enhances chemosensitivity to doxorubicin in lung adenocarcinoma A549 cells.
Sonoki H; Tanimae A; Furuta T; Endo S; Matsunaga T; Ichihara K; Ikari A
J Nutr Biochem; 2018 Jun; 56():205-214. PubMed ID: 29597147
[TBL] [Abstract][Full Text] [Related]
40. Carfilzomib inhibits the growth of lung adenocarcinoma via upregulation of Gadd45a expression.
Yang F; Liu WW; Chen H; Zhu J; Huang AH; Zhou F; Gan Y; Zhang YH; Ma L
J Zhejiang Univ Sci B; 2020 Jan.; 21(1):64-76. PubMed ID: 31898443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
